RETROVIR
zidovudine
- Strength
- 100 mg/1
- Form
- Capsule
- Class
- Human Immunodeficiency Virus Nucleoside…
ViiV Healthcare Company
zidovudine
Listed by ViiV Healthcare Company
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 49702-213 |
| FDA application | NDA019951 |
| RxNorm concept | 108396 |
| Package sizes listed | 1 |
| Marketed since | November 2010 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
zidovudine
ViiV Healthcare Company
zidovudine
ViiV Healthcare Company
Aurobindo Pharma Limited
Camber Pharmaceuticals, Inc.
Aurobindo Pharma Limited
Coupler LLC
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.